Evidence map›Paper›PMID 31547758›Full record

ArticleInnate immunity2020

Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma.

Sharareh Gholamin, Osama A Youssef, Marjan Rafat, Rogelio Esparza, Suzana Kahn, Maryam Shahin, Amato J Giaccia, Edward E Graves, Irving Weissman, Siddhartha Mitra and 1 more

Abstract read
In one paragraph

Article in Innate immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Deciphering the role of CD47 in cancer immunotherapy.Journal of advanced research · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sharareh GholaminDivision of Pediatric Neurosurgery, Department of Neurosurgery, Lucile Packard Children's Hospital, Stanford University School of Medicine, USA.
Osama A YoussefDivision of Pediatric Neurosurgery, Department of Neurosurgery, Huntsman Cancer Institute, School of Medicine, University of Utah, USA.
Marjan RafatDepartment of Radiation Oncology, Stanford University, USA.
Rogelio EsparzaDivision of Pediatric Neurosurgery, Department of Neurosurgery, Lucile Packard Children's Hospital, Stanford University School of Medicine, USA.
Suzana KahnDivision of Pediatric Neurosurgery, Department of Neurosurgery, Lucile Packard Children's Hospital, Stanford University School of Medicine, USA.
Maryam ShahinDepartment of Radiation Oncology, Stanford University, USA.
Amato J GiacciaDepartment of Radiation Oncology, Stanford University, USA.
Edward E GravesDepartment of Radiation Oncology, Stanford University, USA.
Irving WeissmanInstitute for Stem Cell Biology and Regenerative Medicine and the Stanford Ludwig Cancer Center, Stanford University School of Medicine, USA.
Siddhartha MitraDivision of Pediatric Neurosurgery, Department of Neurosurgery, Lucile Packard Children's Hospital, Stanford University School of Medicine, USA.
Samuel H CheshierDivision of Pediatric Neurosurgery, Department of Neurosurgery, Lucile Packard Children's Hospital, Stanford University School of Medicine, USA.ORCID 0000-0003-4983-6610

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Vittorio Sebastiano · 2007 to 2026
$71.4M
Radiation-Induced Tumor Cell MigrationR01CA197136 · NCI · STANFORD UNIVERSITY · PI GRAVES, EDWARD E. · 2015 to 2019
$1.9M
Cancer Research UK 28736Medical Research Council MC_UU_00001/8NCI NIH HHS R01 CA197136
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntineoplastic Agents, AlkylatingBrain NeoplasmsCD47 AntigenCell Line, TumorCombined Modality TherapyGlioblastomaHumansImmunotherapyMacrophagesMicePhagocytosisTemozolomideXenograft Model Antitumor AssaysAntineoplastic Agents, AlkylatingCD47 AntigenCD47 protein, humanTemozolomideanti-CD47Glioblastomairradiationmacrophagesphagocytosistemozolomide

Identifiers

PMID31547758
PMCPMC7016411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.